BridgeMD
New treatment option for Hallucinations, Verbal Auditory
Official title Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06013748
What this study is testing
- What it's testing
- Rationale: Auditory verbal hallucinations (AVH) - hearing voices that others cannot hear - are common in mental illnesses. For many people AVH are distressing, disabling and persistent, despite medication.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- Having a DSM-5 diagnosis of a psychiatric disorder
- Distressing AVH for minimally 3 months.
- Age 16 years or older
You likely can't join if
- Insufficient command of the Dutch language
- Unable to provide informed consent
- Primary diagnosis of a substance use disorder, or organic brain disease (such as dementia)
- A degree of substance abuse that hinders treatment adherence
- Auditory verbal hallucinations in a language not spoken by therapists
- Patients cannot receive CBT specifically focused at gaining empowerment over voices during the study period or 6 months prior to enrolment.
The study team makes the final eligibility decision.
Where it's taking place
- Groningen, Provincie Groningen, Netherlands
- Assen, Netherlands
- Groningen, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Groningen, Provincie Groningen, Netherlands; Assen, Netherlands; Groningen, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.